Peripheral Nervous System Diseases clinical trials

The registry lists 476 studies for Peripheral Nervous System Diseases across more than 10 countries. 103 are recruiting or about to start. 177 of them are mainly about Peripheral Nervous System Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its 40 narrower conditions too, such as Diabetic Foot: 5,937 studies, 1,435 open.

Get an email when these change. Save the Peripheral Nervous System Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 245
Recruiting: 65
Status unknown: 52
Not yet recruiting: 36
Terminated: 33
Active, not recruiting: 28

Phase

Phase 2: 91
Phase 3: 59
Phase 1: 25
Phase 4: 16

Where

United States: 191
Egypt: 31
France: 31
Germany: 26
United Kingdom: 25
Turkey: 25

Who runs them

NeurogesX (11) · Mayo Clinic (7) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Assiut University (6) · Washington University School of Medicine (6) · National Taiwan University Hospital (6) · M.D. Anderson Cancer Center (5) · National Institute of Neurological Disorders and Stroke (NINDS) (5)

What is being tested here

Drugs under test in Peripheral Nervous System Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Adezunap	4	4	4
Pregabalin	2	5	7
Duloxetine	1	3	6
Acetylcysteine	1	0	3
Immunoglobulin G	1	1	3
Venlafaxine	1	0	2
Mecobalamin	1	1	2
Immunoglobulins, Intravenous	1	0	2
Vitamin D	1	0	2
Amantadine	1	0	1

Drug classes tested here SNRIs 2 open · Local anesthetics 7 · Opioids 7

Coming up

13phase 3 studies under way

45studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Apr 2027Neuroprotection of Memantine and Rosuvastatin · Phase 3 · Tanta University
Jun 2027Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia · Phase 3 · Brainfarma Industria Química e Farmacêutica S/A
Jul 2027A Phase 3 Study of NTLA-2001 in ATTRv-PN · Phase 3 · Intellia Therapeutics
Nov 2026Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life · Taipei Veterans General Hospital, Taiwan
Dec 2026Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain · Dogwood Therapeutics Inc.
Dec 2026Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends · Axogen Corporation
Dec 2026This Study Aims to Investigate the Efficacy of Photobiomodulation in the Treatment of Anti-MAG-induced Peripheral Neuropathy (LASER-MAG) · Centre Hospitalier de Cornouaille
Dec 2026Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma · Comprehensive Cancer Center Munich (CCCM)
Dec 2026The Role of TRP Channels in CIPN · Universitaire Ziekenhuizen KU Leuven
Dec 2026Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy · Centre Antoine Lacassagne

Who these studies take

Of the 65 Peripheral Nervous System Diseases studies recruiting now, 44 (68%) set no upper age limit and 10 (15%) stop at 75 or younger. 8 (12%) take children under 18. 2 (3%) are for women only and 0 (0%) for men only; 10 (15%) take healthy volunteers.

Recruiting studies that take each age, of 65
Age	Women	Men
10	6 (9%)	6 (9%)
18	59 (91%)	57 (88%)
30	60 (92%)	58 (89%)
40	61 (94%)	59 (91%)
50	62 (95%)	60 (92%)
65	62 (95%)	60 (92%)
75	60 (92%)	58 (89%)
85	50 (77%)	48 (74%)

Across all 476 studies, recruiting or not: 25% stop at 75 or younger and 11% at 65; 10% take children; 9% are for women only and 1% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Peripheral Nervous System Diseases studies take

Of 20 phase 2 interventional studies under Peripheral Nervous System Diseases, half reached primary completion within 26 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Phase 2	26 mo13–49 · 20 studies	—	—
Interventional, no phase	25 mo12–43 · 132 studies	—	25 mo12–43 · 122 studies
Observational	43 mo16–93 · 38 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 476. Browse all 476 → or search them.